These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16731214)

  • 1. Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression.
    Chan KL; Campayo A; Moser DJ; Arndt S; Robinson RG
    Arch Phys Med Rehabil; 2006 Jun; 87(6):793-8. PubMed ID: 16731214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antidepressants on the course of disability following stroke.
    Mikami K; Jorge RE; Adams HP; Davis PH; Leira EC; Jang M; Robinson RG
    Am J Geriatr Psychiatry; 2011 Dec; 19(12):1007-15. PubMed ID: 21358384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial.
    Kimura M; Robinson RG; Kosier JT
    Stroke; 2000 Jul; 31(7):1482-6. PubMed ID: 10884441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.
    Fiedorowicz JG; Takezawa K; Robinson RG
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):399-405. PubMed ID: 18070842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
    Narushima K; Kosier JT; Robinson RG
    J Nerv Ment Dis; 2002 May; 190(5):296-303. PubMed ID: 12011609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
    Jorge RE; Robinson RG; Arndt S; Starkstein S
    Am J Psychiatry; 2003 Oct; 160(10):1823-9. PubMed ID: 14514497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials.
    Kimura M; Tateno A; Robinson RG
    Am J Geriatr Psychiatry; 2003; 11(3):320-7. PubMed ID: 12724111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants.
    Simon GE; VonKorff M; Heiligenstein JH; Revicki DA; Grothaus L; Katon W; Wagner EH
    JAMA; 1996 Jun; 275(24):1897-902. PubMed ID: 8648870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
    Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.
    Fabre LF; Scharf MB; Itil TM
    J Clin Psychiatry; 1991 Jun; 52 Suppl():62-7. PubMed ID: 2050651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects.
    Coccaro EF; Kavoussi RJ
    Arch Gen Psychiatry; 1997 Dec; 54(12):1081-8. PubMed ID: 9400343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-stroke depression impedes recovery.
    Health News; 2000 Sep; 6(9):7. PubMed ID: 10997111
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.